"MEDEZE" Presented to Investors in Chiang Mai, Prepares for IPO Offering to List on SET
On September 8, 2024, Dr. Veerapol Khemarangsan (2nd from left), Chief Executive Officer; Mr. Pipat Pisanuwongruk (1st from left), Chief Accounting and Financial Officer of MEDEZE Treasury PTE. LTD.; Ms. Danita Phithaknetikun (3rd from right), Chief Business Development Officer; Assoc. Prof. Dr. Paiboon Sereewiwattana (2nd from right), Financial Planning Advisor of MEDEZE Group Public Company Limited (MEDEZE), a leading provider of stem cell analysis, isolation, cultivation, and storage services, as well as immune cell (NK Cell) potential evaluation, were joined by Mr. Pawarit Wesssupharat (1st from right), Deputy Director of Investment Banking at Yuanta Securities (Thailand) Co., Ltd., acting as the financial advisor and lead manager for the offering of additional common shares.
Together, they presented detailed information to investors at the Retail Investor Roadshow in preparation for MEDEZE’s Initial Public Offering (IPO) of 268 million shares to be listed on the Stock Exchange of Thailand (SET). The event was held at the Grand Ballroom, 2nd Floor, Chiang Mai Marriott Hotel.
IR Press Releases